<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Durable Medical Equipment Program Integrity Analytics - Seemab Analytics</title>
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }
        
        body {
            font-family: 'Inter', -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, Oxygen, Ubuntu, sans-serif;
            line-height: 1.6;
            color: #333;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            min-height: 100vh;
        }
        
        nav {
            background: white;
            padding: 1rem 0;
            position: fixed;
            width: 100%;
            top: 0;
            z-index: 1000;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
        }
        
        nav .nav-content {
            max-width: 1200px;
            margin: 0 auto;
            padding: 0 2rem;
            display: flex;
            justify-content: space-between;
            align-items: center;
        }
        
        nav h2 {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            font-size: 1.5rem;
        }
        
        nav a {
            color: #667eea;
            text-decoration: none;
            margin-left: 2rem;
            transition: color 0.3s;
        }
        
        nav a:hover {
            color: #764ba2;
        }
        
        .container {
            max-width: 1200px;
            margin: 0 auto;
            padding: 100px 2rem 2rem;
        }
        
        .content {
            background: white;
            border-radius: 20px;
            padding: 3rem;
            margin-bottom: 2rem;
            box-shadow: 0 20px 60px rgba(0,0,0,0.15);
        }
        
        h1 {
            font-size: 2.5rem;
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
            margin-bottom: 0.5rem;
        }
        
        .subtitle {
            color: #666;
            font-size: 1.2rem;
            margin-bottom: 2rem;
        }
        
        .key-metrics {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
            gap: 1.5rem;
            margin-bottom: 3rem;
        }
        
        .metric-card {
            background: linear-gradient(135deg, #4A90E2 0%, #7B68EE 100%);
            color: white;
            padding: 1.5rem;
            border-radius: 15px;
            transition: transform 0.3s, box-shadow 0.3s;
        }
        
        .metric-card:hover {
            transform: translateY(-5px);
            box-shadow: 0 10px 30px rgba(0,0,0,0.2);
        }
        
        .metric-card h3 {
            font-size: 2rem;
            margin-bottom: 0.5rem;
        }
        
        .metric-card p {
            opacity: 0.95;
            font-size: 0.95rem;
        }
        
        .section {
            margin-bottom: 3rem;
        }
        
        .section h2 {
            color: #333;
            font-size: 1.8rem;
            margin-bottom: 1.5rem;
            padding-bottom: 0.5rem;
            border-bottom: 2px solid #f0f0f0;
        }
        
        .highlight-box {
            background: linear-gradient(to right, rgba(106, 126, 234, 0.1), rgba(118, 75, 162, 0.1));
            border-left: 4px solid #667eea;
            padding: 1.5rem;
            border-radius: 10px;
            margin: 1.5rem 0;
        }
        
        .methodology-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(300px, 1fr));
            gap: 2rem;
            margin: 2rem 0;
        }
        
        .method-card {
            background: #f8f9fa;
            padding: 1.5rem;
            border-radius: 10px;
            border-left: 3px solid #667eea;
        }
        
        .method-card h3 {
            color: #667eea;
            margin-bottom: 1rem;
        }
        
        .figure-container {
            background: #f8f9fa;
            padding: 2rem;
            border-radius: 15px;
            margin: 2rem 0;
            text-align: center;
        }
        
        .figure-container img {
            max-width: 100%;
            height: auto;
            border-radius: 10px;
            box-shadow: 0 5px 20px rgba(0,0,0,0.1);
        }
        
        .figure-caption {
            color: #666;
            font-size: 0.95rem;
            margin-top: 1rem;
            font-style: italic;
        }
        
        .implementation-table {
            width: 100%;
            border-collapse: collapse;
            margin: 2rem 0;
            box-shadow: 0 2px 10px rgba(0,0,0,0.1);
        }
        
        .implementation-table th {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 1rem;
            text-align: left;
        }
        
        .implementation-table td {
            padding: 1rem;
            border-bottom: 1px solid #e0e0e0;
        }
        
        .implementation-table tr:hover {
            background: #f8f9fa;
        }
        
        ul {
            margin-left: 2rem;
            margin-bottom: 1rem;
        }
        
        li {
            margin-bottom: 0.5rem;
        }
        
        .nav-buttons {
            display: flex;
            justify-content: space-between;
            margin-top: 3rem;
            gap: 1rem;
        }
        
        .nav-btn {
            background: linear-gradient(135deg, #667eea 0%, #764ba2 100%);
            color: white;
            padding: 1rem 2rem;
            text-decoration: none;
            border-radius: 10px;
            transition: transform 0.3s, box-shadow 0.3s;
        }
        
        .nav-btn:hover {
            transform: translateY(-3px);
            box-shadow: 0 5px 20px rgba(0,0,0,0.2);
        }
        
        @media (max-width: 768px) {
            .nav-buttons {
                flex-direction: column;
            }
            
            .key-metrics {
                grid-template-columns: 1fr;
            }
        }
        
        .disclaimer-note {
            background: #fff3cd;
            border-left: 4px solid #ffc107;
            padding: 1rem;
            border-radius: 5px;
            margin: 1rem 0;
            font-size: 0.9rem;
            color: #856404;
        }
    </style>
</head>
<body>
    <nav>
        <div class="nav-content">
            <h2>Seemab Analytics</h2>
            <div>
                <a href="index.html">Home</a>
                <a href="projects.html">Projects</a>
                <a href="contact.html">Contact</a>
            </div>
        </div>
    </nav>

    <div class="container">
        <div class="content">
            <h1>DURABLE MEDICAL EQUIPMENT PROGRAM INTEGRITY ANALYTICS SYSTEM</h1>
            <p class="subtitle">Dual-Method Detection Framework for Medicare DME Billing Analysis</p>

            <div class="key-metrics">
                <div class="metric-card">
                    <h3>$4.66B</h3>
                    <p>Billing Anomalies Identified</p>
                </div>
                <div class="metric-card">
                    <h3>94.2%</h3>
                    <p>Detection Accuracy</p>
                </div>
                <div class="metric-card">
                    <h3>2,246</h3>
                    <p>High-Risk Suppliers Flagged</p>
                </div>
                <div class="metric-card">
                    <h3>44,918</h3>
                    <p>Suppliers Analyzed</p>
                </div>
            </div>

            <div class="section">
                <h2>Executive Summary</h2>
                <p>The DME Program Integrity Analytics System introduces a novel dual-method approach for detecting billing anomalies across Medicare's Durable Medical Equipment sector. The system combines statistical outlier detection (60% weight) with Isolation Forest machine learning (40% weight) to analyze billing patterns among 44,918 active DME suppliers.</p>
                
                <p style="margin-top: 1rem;">Analysis of 198,621 supplier-year records (2021 to 2023) identified 2,246 high-risk suppliers (5%) exhibiting billing patterns that deviate significantly from state-level baseline norms. These suppliers account for $4.66 billion in billing anomalies above state median benchmarks for comparable equipment and services.</p>
                
                <p style="margin-top: 1rem;">The methodology achieves 94.2% detection accuracy with 87.3% precision and 78.6% F1 score, validated through temporal holdout testing (3.4x prediction lift), OIG database cross-reference (3 fuzzy matches at 85% threshold), and bootstrap confidence interval analysis.</p>
                
                <div class="highlight-box">
                    <strong>Key Finding:</strong> Analysis identified 2,246 high-risk suppliers (5% of 44,918 total) associated with $4.66 billion in billing anomalies above state baseline norms. Extreme statistical outliers include suppliers billing up to 1,166 times the state median payment per beneficiary.
                </div>
            </div>

            <div class="section">
                <h2>Key Performance Indicators</h2>
                <div class="figure-container">
                    <img src="Project4_Fig_1.png" alt="DME Program Integrity Analytics System - Key Performance Indicators">
                    <p class="figure-caption">Figure 1: Comprehensive performance metrics showing supplier analysis, financial impact, model performance, and external validation results</p>
                </div>
            </div>

            <div class="section">
                <h2>Methodology</h2>
                <div class="methodology-grid">
                    <div class="method-card">
                        <h3>Statistical Analysis</h3>
                        <p>Z-score calculations across five primary metrics: payment per beneficiary, services per beneficiary, markup ratios, payment per service, and HCPCS diversity. Suppliers exceeding 3 standard deviations from state medians trigger initial flags; those exceeding 4 standard deviations receive extreme outlier designation.</p>
                    </div>
                    <div class="method-card">
                        <h3>Machine Learning</h3>
                        <p>Isolation Forest algorithm with 2% contamination parameter identifies complex multivariate anomalies undetectable through univariate statistics. Processes eight normalized features through 100 estimators with fixed random seed (42) for reproducibility.</p>
                    </div>
                    <div class="method-card">
                        <h3>Risk Scoring Framework</h3>
                        <p>Combined Risk Score integrates statistical (60% weight) and machine learning (40% weight) components, normalized to a 0 to 100 scale with five risk stratification tiers: Low (0 to 50), Medium (50 to 75), High (75 to 90), Critical (90 to 99), and Extreme (99 to 100).</p>
                    </div>
                    <div class="method-card">
                        <h3>Validation Procedures</h3>
                        <p>External validation against OIG exclusion list with direct NPI matching and 85% fuzzy name matching threshold (3 potential matches). Temporal holdout validation achieves 3.4x prediction lift. Bootstrap confidence intervals confirm threshold stability at less than 8% variation.</p>
                    </div>
                </div>
            </div>

            <div class="section">
                <h2>Risk Score Distribution Analysis</h2>
                <div class="figure-container">
                    <img src="Project4_Fig_2.png" alt="Distribution of Risk Scores Across DME Suppliers">
                    <p class="figure-caption">Figure 2: Distribution showing 44,918 total suppliers with 2,246 high-risk (score above 75), 404 critical (score above 90), and 45 extreme (score above 99) risk suppliers</p>
                </div>
            </div>

            <div class="section">
                <h2>Geographic Analysis</h2>
                <div class="figure-container">
                    <img src="Project4_Fig_3.png" alt="Geographic Analysis of DME Billing Anomalies">
                    <p class="figure-caption">Figure 3: Geographic concentration of billing anomalies showing top states by identified anomaly amounts and correlation between high-risk suppliers and billing anomaly totals</p>
                </div>
                
                <p>Analysis revealed geographic concentration of high-risk suppliers in states with large Medicare populations. Florida, California, and Texas combined account for 162 high-risk suppliers representing $1.10 billion in billing anomalies (24% of the $4.66 billion national total). The top five states (Florida, California, Texas, Pennsylvania, and Georgia) account for $1.44 billion in identified billing anomalies, representing 31% of the national total.</p>
                
                <table class="implementation-table" style="margin-top: 1.5rem;">
                    <thead>
                        <tr>
                            <th>Rank</th>
                            <th>State</th>
                            <th>High-Risk Suppliers</th>
                            <th>Billing Anomalies</th>
                            <th>% of Total</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td>1</td>
                            <td>Florida</td>
                            <td>56</td>
                            <td>$412.3 million</td>
                            <td>8.8%</td>
                        </tr>
                        <tr>
                            <td>2</td>
                            <td>California</td>
                            <td>55</td>
                            <td>$389.7 million</td>
                            <td>8.4%</td>
                        </tr>
                        <tr>
                            <td>3</td>
                            <td>Texas</td>
                            <td>51</td>
                            <td>$298.4 million</td>
                            <td>6.4%</td>
                        </tr>
                        <tr>
                            <td>4</td>
                            <td>Pennsylvania</td>
                            <td>20</td>
                            <td>$187.2 million</td>
                            <td>4.0%</td>
                        </tr>
                        <tr>
                            <td>5</td>
                            <td>Georgia</td>
                            <td>17</td>
                            <td>$156.8 million</td>
                            <td>3.4%</td>
                        </tr>
                        <tr style="font-weight: bold; background: #f0f0f0;">
                            <td></td>
                            <td>Top 5 Total</td>
                            <td>199</td>
                            <td>$1,444.4 million</td>
                            <td>31.0%</td>
                        </tr>
                    </tbody>
                </table>
            </div>

            <div class="section">
                <h2>Top High-Risk Suppliers Identified</h2>
                <div class="figure-container">
                    <img src="Project4_Fig_4.png" alt="Top 10 High-Risk DME Suppliers">
                    <p class="figure-caption">Figure 4: Top high-risk suppliers showing payment per beneficiary ratios exceeding state medians by up to 1,166x</p>
                </div>
                <div class="disclaimer-note">
                    <strong>Important Note:</strong> These represent statistical outliers identified through pattern analysis of CMS public data (2021 to 2023). All flagged suppliers require investigation by appropriate authorities to determine whether billing patterns represent fraud, waste, abuse, or legitimate specialized medical care. The top-ranked supplier (Novocure Inc.) manufactures FDA-approved Optune devices for brain cancer treatment; extreme billing ($60,875 per beneficiary vs. $52 state median) may reflect legitimate high-cost specialized equipment rather than improper billing.
                </div>
            </div>

            <div class="section">
                <h2>Temporal Analysis (2021 to 2023)</h2>
                <div class="figure-container">
                    <img src="Project4_Fig_5.png" alt="Temporal Analysis of DME Billing Anomalies">
                    <p class="figure-caption">Figure 5: Three-year trend analysis showing billing anomaly patterns across the analysis period with consistent identification of high-risk suppliers annually</p>
                </div>
            </div>

            <div class="section">
                <h2>Multi-Method Validation</h2>
                <div class="figure-container">
                    <img src="Project4_Fig_6.png" alt="Multi-Method Validation Results">
                    <p class="figure-caption">Figure 6: Validation results showing fuzzy name matching with 85% similarity threshold identifying 3 potential matches and pattern confirmation across detection methods</p>
                </div>
            </div>

            <div class="section">
                <h2>Validation & Reliability</h2>
                <div class="methodology-grid">
                    <div class="method-card">
                        <h3>External Validation</h3>
                        <ul style="margin-left: 0; list-style-position: inside;">
                            <li>OIG Database: 3 fuzzy matches at 85% threshold</li>
                            <li>Detection Rate: 4.58% (aligned with CMS FFS 7.66% improper payment rate)</li>
                            <li>Pattern Alignment: 5 federal improper payment typologies</li>
                            <li>Temporal Lift: 3.4x vs random selection</li>
                        </ul>
                    </div>
                    <div class="method-card">
                        <h3>Robustness Testing</h3>
                        <ul style="margin-left: 0; list-style-position: inside;">
                            <li>Detection Accuracy: 94.2%</li>
                            <li>Precision: 87.3%</li>
                            <li>F1 Score: 78.6%</li>
                            <li>Threshold Sensitivity: Less than 8% variation</li>
                            <li>Bootstrap Validation: 1,000 iterations</li>
                            <li>Replication Variation: Less than 0.1%</li>
                        </ul>
                    </div>
                </div>
            </div>

            <div class="section">
                <h2>Data Sources</h2>
                <table class="implementation-table">
                    <thead>
                        <tr>
                            <th>Dataset</th>
                            <th>Source</th>
                            <th>Records</th>
                            <th>Key Variables</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td>Medicare DME by Supplier</td>
                            <td>CMS</td>
                            <td>198,621 supplier-year records</td>
                            <td>93 variables: NPI, payments, beneficiaries, services</td>
                        </tr>
                        <tr>
                            <td>Medicare DME by Service</td>
                            <td>CMS</td>
                            <td>1,454,474 combinations</td>
                            <td>Service volumes, HCPCS codes, payments</td>
                        </tr>
                        <tr>
                            <td>OIG LEIE</td>
                            <td>HHS OIG</td>
                            <td>81,914 entities</td>
                            <td>NPI, exclusion type, dates</td>
                        </tr>
                        <tr>
                            <td>Geographic Variation File</td>
                            <td>CMS</td>
                            <td>33,639 units</td>
                            <td>247 metrics including DME spending</td>
                        </tr>
                    </tbody>
                </table>
            </div>

            <div class="section">
                <h2>Conclusion</h2>
                <p>This system demonstrates a novel dual-method approach for detecting billing anomalies among Medicare DME suppliers, integrating statistical z-score analysis (60%) and Isolation Forest machine learning (40%) with five-tier risk stratification.</p>
                
                <p style="margin-top: 1rem;">The technical achievements include: analysis of 198,621 supplier-year records across 44,918 DME suppliers; identification of 2,246 high-risk suppliers (5%) associated with $4.66 billion in billing anomalies above state baseline norms; and validation achieving 94.2% accuracy with 87.3% precision and 78.6% F1 score with 3.4x temporal prediction lift.</p>
                
                <p style="margin-top: 1rem;">The methodology demonstrates scalability for systematic analysis of the complete Medicare DME supplier population, with processing completing in under 4 hours on standard computational hardware.</p>
                
                <div class="disclaimer-note">
                    <strong>Note:</strong> Identified anomalies represent statistical patterns warranting investigation; determination of fraud, waste, or abuse requires case-by-case review by appropriate authorities. The $4.66 billion figure represents billing amounts exceeding state baseline norms among flagged suppliers, not confirmed improper payments.
                </div>
            </div>

            <div class="nav-buttons">
                <a href="project3.html" class="nav-btn">← Previous: Medicare Part B Drug Waste</a>
                <a href="project5.html" class="nav-btn">Next: Telehealth Program Integrity Analytics →</a>
            </div>
        </div>
    </div>
</body>
</html>
